“…Available scoring systems for assessing the severity and prognosis of AH are Modified MDF based on PT and serum bilirubin concentration; GAHS that uses variables including age, blood urea, peripheral blood leukocyte count, serum bilirubin, and PT; the MELD score using bilirubin, creatinine, and INR levels; the Lille model which combines six variables (age, renal insufficiency, albumin, PT, bilirubin, and evolution of bilirubin on day 7). Scoring systems include differing cut-offs, various clinical and laboratory parameters; combining more than one scoring system, as well as establishing new scoring models, could improve the current practice [8]. CH is symptomatic, biochemical, or serological evidence of continuing or relapsing hepatic disease for more than six months.…”